Anli Yang - Publications, H-index & Citations

Anli Yang

Sun Yat-sen University Cancer Center

29H指数

147论文数

2.4K被引数

收录论文 48

发表时间

Germline Pathogenic Variants in HER2-Positive Breast Cancer: Spectrum and Clinical Implications in a High-Risk Chinese Cohort HER2阳性乳腺癌中的胚系致病性变异：高风险中国队列中的谱系及临床意义

Cancer Medicine

IF3.1

2026-05-15

OAAI

Lijia Zhou; Mengqian Ni; Anli Yang; Qingru Zhou; Daining Wang; Shu Dun; Fei Xu; Jiajia Huang; Xiwen Bi; Wen Xia; Ruoxi Hong; Qiufan Zheng; Meiting Chen; Kuikui Jiang; Jun Tang; Xi Wang; Zhongyu Yuan; Shusen Wang; Yanxia Shi; Fang Wang; Xin An

RM2Target v2.0: an updated database for the target genes of writers, erasers, and readers of RNA modifications RM2Target v2.0：一个关于RNA修饰的writers、erasers和readers靶基因的更新数据库

NUCLEIC ACIDS RESEARCH

IF13.1

2025-11-01

PREAI

Bao, Xiaoqiong; Jiang, Qi; Chen, Weixuan; Li, Huiqin; Li, Xuanye; Zuo, Xiangyu; Lin, Zhuobin; Huang, Yuantai; Li, Lingxiao; Yang, Anli; Ren, Jian; Zuo, Zhixiang

Efficacy and Safety of T-DXd in HER2+ and Low/Zero Metastatic BCBM: A Retrospective Multicenter Real-World Study T-DXd在HER2+和低/零转移性乳腺癌脑转移（BCBM）中的有效性与安全性：一项回顾性多中心真实世界研究

Cancer Science

IF4.3

2025-09-11

OAAI

Qingru Zhou; Yuanyuan Li; Ni He; Guorong Zou; Mengqian Ni; Lulu Zhang; Shu Dun; Zhanhong Chen; Kejun Liu; Yabing Cao; Jiajia Huang; Fei Xu; Zhongyu Yuan; Shusen Wang; Yanxia Shi; Yonggao Mou; Anli Yang; Lixia Li; Xin An

HER2-positive breast cancer with invasive micropapillary carcinoma component shows immunosuppressive microenvironment and resistance to neoadjuvant therapy HER2阳性伴有浸润性微乳头状癌成分的乳腺癌表现出免疫抑制性微环境和对新辅助治疗的抵抗

Frontiers in Immunology

IF5.9

2025-08-02

OAAI

Lulu Zhang†; Lijia Zhou†; Anli Yang†; Shaoquan Zheng; Keming Chen; Yutian Zou; Qingru Zhou; Daining Wang; Fei Xu; Jiajia Huang; Zhongyu Yuan; Shusen Wang; Yanxia Shi; Peng Sun; Xin An

crVDAC3 alleviates ferroptosis by impeding HSPB1 ubiquitination and confers trastuzumab deruxtecan resistance in HER2-low breast cancer crVDAC3通过阻止HSPB1泛素化减轻铁死亡并赋予HER2-low乳腺癌对曲妥珠单抗deruxtecan的耐药性

DRUG RESISTANCE UPDATES

IF21.7

2024-11-01

PREAI

Zou, Yutian; Yang, Anli; Chen, Bo; Deng, Xinpei; Xie, Jindong; Dai, Danian; Zhang, Jinhui; Tang, Hailin; Wu, Tao; Zhou, Zhigang; Xie, Xiaoming; Wang, Jin

Eribulin plus carboplatin combination for HER2-negative metastatic breast cancer: a multicenter, real-world cohort study

BMC CANCER

IF3.4

2024-09-30

OAAI

Ni, Mengqian; Zhou, Lijia; Lu, Yongkui; Guo, Dachuan; Li, Xiuyue; Li, Lixia; Zhang, Lidong; Chen, Meiting; Zhang, Lulu; Xu, Fei; Yuan, Zhongyu; Wang, Shusen; Shi, Yanxia; Yang, Anli; An, Xin

NIR-Triggered Release of Nitric Oxide by Upconversion-Based Nanoplatforms to Enhance Osteogenic Differentiation of Mesenchymal Stem Cells for Osteoporosis Therapy

BIOMATERIALS RESEARCH

IF9.6

2024-07-22

OAAI

Ma, Xulu; Luan, Zhao; Zhao, Qingxin; Yang, Anli; Li, Jinming

Single-cell RNA sequencing elucidated the landscape of breast cancer brain metastases and identified ILF2 as a potential therapeutic target

CELL PROLIFERATION

IF5.6

2024-06-29

OAAI

Xie, Jindong; Yang, Anli; Liu, Qianwen; Deng, Xinpei; Lv, Guangzhao; Ou, Xueqi; Zheng, Shaoquan; Situ, Min-Yi; Yu, Yang; Liang, Jie-Ying; Zou, Yutian; Tang, Hailin; Zhao, Zijin; Lin, Fuhua; Liu, Wei; Xiao, Weikai

MLLT6/ATF2 Axis Restrains Breast Cancer Progression by Driving DDIT3/4 Expression

MOLECULAR CANCER RESEARCH

IF4.7

2024-05-17

PREAI

Yu, Qing; Zhao, Jiayi; Yang, Anli; Li, Xiangxin

Integrated diagnosis and treatment of upconversion nanocomposite hydrogel for osteoarthritis treatment

CHEMICAL ENGINEERING JOURNAL

IF13.2

2024-05-01

PREAI

Luan, Zhao; Ma, Xulu; Zhao, Qingxin; Yang, Anli; Li, Jinming

Identification and validation of immune-related methylation clusters for predicting immune activity and prognosis in breast cancer (vol 12, 704557, 2021)

FRONTIERS IN IMMUNOLOGY

IF5.9

2024-01-31

OAAI

Yang, Anli; Zhou, Ying; Kong, Yanan; Wei, Xiaoli; Ye, Feng; Zhang, Lijuan; Zhong, Xian; Li, Mingyue; Lu, Shilin; An, Xin; Xiao, Weikai

Efficacy and safety of eribulin plus carboplatin combination for HER2-negative metastatic breast cancer

ANNALS OF ONCOLOGY

IF65.4

2023-11-01

PREAI

Ni, M.; Zhou, L.; Lu, Y.; Zhang, L.; Li, X.; Chen, M.; Yang, A.; Zhang, L.; Xu, F.; Yuan, Z.; Wang, S.; Shi, Y.; An, X.

Multi-omics analyses unravel DNA damage repair-related clusters in breast cancer with experimental validation

FRONTIERS IN IMMUNOLOGY

IF5.9

2023-10-31

OAAI

Liu, Peng; Deng, Xinpei; Zhou, Huamao; Xie, Jindong; Kong, Yanan; Zou, Yutian; Yang, Anli; Li, Xing

Retroauricular Single-Site Endoscopic Thyroidectomy-A Balanced Endoscopic Approach for Thyroid Excision

JAMA SURGERY

IF14.9

2023-05-01

PREAI

Dong, Fan; Yang, Anli; Ouyang, Dian

Dissecting the role of cancer-associated fibroblast-derived biglycan as a potential therapeutic target in immunotherapy resistance: A tumor bulk and single-cell transcriptomic study 剖析癌症相关的成纤维细胞衍生的双糖链蛋白聚糖作为免疫疗法抵抗的潜在治疗靶标的作用: 肿瘤本体和单细胞转录组学研究

CLINICAL AND TRANSLATIONAL MEDICINE

IF6.8

2023-02-11

OAAI

Zheng, Shaoquan; Liang, Jie-Ying; Tang, Yuhui; Xie, Jindong; Zou, Yutian; Yang, Anli; Shao, Nan; Kuang, Xiaying; Ji, Fei; Liu, Xuefeng; Tian, Wenwen; Xiao, Weikai; Lin, Ying

Near-Infrared Light-Controlled and Real-Time Detection of Osteogenic Differentiation in Mesenchymal Stem Cells by Upconversion Nanoparticles for Osteoporosis Therapy

ACS NANO

IF16

2022-05-16

PREAI

Yan, Rui; Guo, Yujiao; Wang, Xichao; Liang, Guohai; Yang, Anli; Li, Jinming

Near-Infrared Light-Controlled Activation of Adhesive Peptides Regulates Cell Adhesion and Multidifferentiation in Mesenchymal Stem Cells on an Up-Conversion Substrate 粘附肽的近红外光控激活调节上转换基质上的间充质干细胞的细胞粘附和多分化

NANO LETTERS

IF9.1

2022-03-03

PREAI

Guo, Yujiao; Yan, Rui; Wang, Xichao; Liang, Guohai; Yang, Anli; Li, Jinming